|
| Differential treatment and medication analysis of 70 cases of patients with stable coronary heart disease treated by Professor ZHANG Boli |
| Hits 1555 Download times 1301 Received:February 20, 2021 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2021.07.01 |
| Key Words
stable coronary heart disease;medication analysis;data mining;ZHANG Boli |
| Author Name | Affiliation | E-mail | | XIONG Ke | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | HUANG Ming | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LYU Ling | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LI Xiao | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LI Lin | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | ZHANG Han | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | zhanghan0023@126.com |
|
| Abstract
|
| [Objective] To explore the differential treatment and medication rules of stable coronary heart disease treated by Professor ZHANG Boli.[Methods] The newly diagnosed stable coronary heart disease cases of Professor ZHANG Boli were collected,and the database was established. The methods of cluster analysis and association rule analysis were used to analyze the differential treatment and medication rules of Professor ZHANG Boli in treating stable coronary heart disease.[Results] A total of 70 cases were collected,and the main syndrome types were deficiency of both qi and yin and blood stasis,deficiency of qi and phlegm and blood stasis. The total frequency of 70 prescriptions was 1 143 times,and 115 kinds of traditional Chinese medicines were used,among which blood-activating drugs,tonics and phlegm-resolving drugs were used most frequently. According to different syndrome types,there is a certain change rule in prescription medication.[Conclusion] Professor ZHANG Boli often observes the pathogenesis elements and uses monarch drugs in treating stable coronary heart disease. Treatment of temporary symptoms is relatively fixed,and team drugs are commonly used. However,mechanical and simple data mining can not fully reflect the law of drug use,so it is necessary to further optimize and refine the methods and results,so that the results can be truly used in clinical practice.Professor ZHANG Boli should guard the pathogenesis when treating stable coronary heart disease. Flexible use of king medicine. The palliative medication is relatively fixed and can be used universally. |
|
|
|
|
|
|
|
